Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-15 | Aquestive Therapeutics, Inc. | Schobel Alexander...
(Chief Innovation/Tech Officer) |
S | Common Stock | D | 50000 | $6.00 - $6.00 | $300,000 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Barber Daniel
(President and CEO) |
F | Common Stock | D | 37938 | $4.88 - $4.88 | $185,137 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Boyd Peter E.
(See Remark) |
F | Common Stock | D | 8370 | $4.88 - $4.88 | $40,845 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | BRAENDER LORI J
(SVP, General Counsel) |
F | Common Stock | D | 10530 | $4.88 - $4.88 | $51,386 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR
(SVP, Chief Financial Officer) |
F | Common Stock | D | 11705 | $4.88 - $4.88 | $57,120 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Wargacki Stephen
(SVP, Research & Development) |
F | Common Stock | D | 12956 | $4.88 - $4.88 | $63,224 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Jung Cassie
(SVP, Operations) |
F | Common Stock | D | 9432 | $4.88 - $4.88 | $46,028 |
| 2024-03-08 | Aquestive Therapeutics, Inc. | Schobel Alexander...
(Chief Innovation/Tech Officer) |
S | Common Stock | D | 25000 | $5.19 - $5.19 | $129,685 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Schobel Alexander...
(Chief Innovation/Tech Officer) |
F | Common Stock | D | 5895 | $4.88 - $4.88 | $28,767 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | BRAENDER LORI J
(SVP, General Counsel) |
A | Common Stock | A | 135000 | $0.00 - $0.00 | $0 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR
(SVP, Chief Financial Officer) |
A | Common Stock | A | 120000 | $0.00 - $0.00 | $0 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | Schobel Alexander...
(Chief Innovation/Tech Officer) |
A | Common Stock | A | 82500 | $0.00 - $0.00 | $0 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | Kraus Carl N
(Chief Medical Officer) |
A | Common Stock | A | 112500 | $0.00 - $0.00 | $0 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | Barber Daniel
(President and CEO) |
A | Common Stock | A | 242600 | $0.00 - $0.00 | $0 |
| 2023-03-10 | Aquestive Therapeutics, Inc. | Jung Cassie
(SVP, Operations) |
F | Common Stock | D | 1365 | $0.00 - $0.00 | $0 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | Jung Cassie
(SVP, Operations) |
A | Common Stock | A | 101250 | $0.00 - $0.00 | $0 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | Boyd Peter E.
(See Remark) |
A | Common Stock | A | 86250 | $0.00 - $0.00 | $0 |
| 2023-03-10 | Aquestive Therapeutics, Inc. | Wargacki Stephen
(SVP, Research & Development) |
F | Common Stock | D | 1981 | $0.79 - $0.79 | $1,572 |
| 2024-03-07 | Aquestive Therapeutics, Inc. | Wargacki Stephen
(SVP, Research & Development) |
A | Common Stock | A | 112500 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |